Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease

Guoqiao Wang, Yan Li, Chengjie Xiong, Tammie L.S. Benzinger, Brian A. Gordon, Jason Hassenstab, Andrew J. Aschenbrenner, Eric McDade, David B. Clifford, Jorge J. Libre-Guerra, Xinyu Shi, Catherine J. Mummery, Christopher H. van Dyck, James J. Lah, Lawrence S. Honig, Gregg Day, John M. Ringman, William S. Brooks, Nick C. Fox, Kazushi SuzukiJohannes Levin, Mathias Jucker, Paul Delmar, Tobias Bittner, Randall J. Bateman

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science